- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02814396
The Application of Multichannel ECG Analytic System in Cardiovascular Diseases
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Chau C Wu, M.D.,Ph.D.
- Phone Number: 88560 886-2-23123456
- Email: chauchungwu@ntu.edu.tw
Study Contact Backup
- Name: Wan T Ke
- Phone Number: 88558 886-223123456
- Email: t87134@gmail.com
Study Locations
-
-
-
Taipei, Taiwan
- Recruiting
- NTUH
-
Contact:
- chau C Wu, Ph.D, MD
- Phone Number: 88560 886-2-23123456
- Email: chauchungwu@ntu.edu.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Space ventricular repolarization within the proposal does not have to represent functions in heart health and disease. Repolarization dispersion higher than normal levels may allow early diagnosis of CVD.
The BSPM and magnetic diagram (MCG) is a newly developed method for both records, and provide higher spatial resolution than conventional ECG signal but has a high cost and bulky shortcomings. It is impossible in a portable manner. Previously, the investigators have used a 64-channel low TC SQUID MCG equipment to develop and validate two parameters, the so-called QT interval (SIQTc) and T wave propagation (TWP) smoothness index, accurate detection and localization of myocardial ischemia blood.
Description
Inclusion Criteria:
- Patients older than 20 years old.
- with suspected arrhythmia or cardiovascular diseases.
Exclusion criteria
- NO
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Composite cardiovascular outcome
Time Frame: up to 5 years
|
The composite cardiovascular (CV) outcome will be any CV events (coronary, cerebral, or peripheral vascular diseases)
|
up to 5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
With at least 1 cardiovascular risk factor.
Time Frame: up to 5 years
|
no evidence of atherosclerotic vascular diseases,with at least 1 cardiovascular risk factor.
|
up to 5 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Chau C WU, M.D.,Ph.D., chauchungwu@ntu.edu.tw
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201207070RIC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multichannel ECG System
-
Meir Medical CenterUnknownPatients With Normal ECG | Patients With Pathological ECGIsrael
-
University Hospital Inselspital, BerneCSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et...UnknownTo Demonstrate That a New Sensor System Can Register Fetal ECG and Distinguish it From Maternal ECGSwitzerland
-
G Medical Innovations Ltd.UnknownRespiration | Oxygen Saturation | Body Temperature | ECGIsrael
-
RWTH Aachen UniversityPfizerCompletedAtrial Fibrillation | ECG | ECG Hand-held Diagnostic ToolGermany
-
Medical University of WarsawNational Center for Research and Development, PolandCompleted
-
Purdue Pharma LPCompleted
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLCCompletedDrug-induced Surface ECG Changes
-
Institut universitaire de cardiologie et de pneumologie...Active, not recruiting
-
Cyberonics, Inc.CompletedECG Comparisons in Normal Healthy SubjectUnited States